Halozyme Therapeutics Inc. (HALO)
Market Closed
3 Jun, 20:00
$
69. 82
+3.54
+5.34%
$
8.08B Market Cap
20.87 P/E Ratio
- Div Yield
2,144,457 Volume
2.74 Eps
$ 66.28
Previous Close 
Want to track HALO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Halozyme Therapeutics Inc. (HALO) Statistics
Valuation metrics
Market Cap 8.08B
Enterprise value 9.96B
Trailing P/E (ttm) 23.97
Forward P/E 6.91
PEG ratio 0.74
Price/Sales (ttm) 5.37
Price/Book (mrq) 36.87
Enterprise Value/Revenue 6.6
Enterprise Value/EBITDA 10.45
Overview
Shares outstanding 118.52M
Float 117.28M
Shares short 14.38M
% Held by insiders 0.01%
% Held by institutions 1.08%
Average volume (10 days) 2.27M
Average volume (90 days) 1.66M
Price summary
52-Week low 51.06
52-Week high 82.22
Beta 0.88
50-Day moving average 65.75
200-Day moving average 69.12
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 171:40
Last split Date 10 Dec 2003
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.23%
Operating margin 0.49%
Operational effectiveness
Return on assets 0.22%
Return on equity 0.99%
Income Statement
Revenue (ttm) 1.51B
Revenue per share (ttm) 12.72
Quarterly revenue growth (yoy) 0.42%
Gross profit (ttm) 1.16B
EBITDA 946.91M
Net income to common (ttm) 348.84M
Diluted EPS (ttm) 2.85
Quarterly earnings growth (yoy) 0.27%
Balance Sheet
Total cash (mrq) 318.62M
Total cash per share (mrq) 2.69
Total debt (mrq) 2.18B
Total Debt/Equity (mrq) 991.21
Current ratio (mrq) 2.76%
Book value per share (mrq) 1.85
Cash Flow
Cash flow statement 677.41M
Levered free cash flow (LFCF) 228.12M
